Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CatSci delivers tailored process research & development solutions for pharmaceutical clients worldwide. The company specializes in small molecule synthesis, oligonucleotide R&D/manufacturing—including RNA therapeutics—and high potency APIs. It provides end-to-end CMC support including route scouting/assessment, analytical method development/validation under cGMP standards, pre-formulation studies and material science. CatSci’s expertise accelerates the delivery of complex medicines by optimizing scalability and sustainability using state-of-the-art facilities and green chemistry principles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CatSci Ltd.